Among all patients with breast cancer without selection bias, the BRCA1/2 mutation retention rate was 4.2–6.1% (BRCA1: 1.45–3.7%, BRCA2: 2.4–3.5%) [48–52]. This evidence concerns the gene BRCA2 and breast cancer.